Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -10.85% is 89% above its 5-year average of -102.76%, near the high end of its 5-year range (-305.19%–-10.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.79% above its 12-month average of -51.13%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -10.85%.
RETURN ON INVESTED CAPITAL (ROIC)
-10.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-131.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-102.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-71.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-66.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+78.79%
CURRENT VS 3Y AVG
+91.78%
CURRENT VS 5Y AVG
+89.45%
CURRENT VS 10Y AVG
+84.80%
CURRENT VS 15Y AVG
+83.67%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
+62.32%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$142.49M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-51.13%
3Y Avg
-131.92%
5Y Avg
-102.76%
Market Cap
$142.11M
Return on Invested Capital (ROIC)
-50.04%
TTM Avg
-28.33%
3Y Avg
-324.90%
5Y Avg
-237.35%
Market Cap
$143.81M
Return on Invested Capital (ROIC)
-134.15%
TTM Avg
-47.87%
3Y Avg
-96.96%
5Y Avg
-96.99%
Market Cap
$146.66M
Return on Invested Capital (ROIC)
-32.73%
TTM Avg
-84.24%
3Y Avg
-68.85%
5Y Avg
-57.28%
Market Cap
$138.26M
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-23.12%
3Y Avg
-29.64%
5Y Avg
-23.50%
Market Cap
$137.29M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$150.59M
Return on Invested Capital (ROIC)
-23.41%
TTM Avg
-38.99%
3Y Avg
-40.72%
5Y Avg
-30.95%
Market Cap
$137.56M
Return on Invested Capital (ROIC)
-7.01%
TTM Avg
-1.96%
3Y Avg
-0.91%
5Y Avg
1.75%
Market Cap
$153.31M
Return on Invested Capital (ROIC)
-165.56%
TTM Avg
-176.54%
3Y Avg
-127.81%
5Y Avg
-112.12%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $142.49M | -10.85% | -51.13% | -131.92% | -102.76% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -50.04% | -28.33% | -324.90% | -237.35% |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | -134.15% | -47.87% | -96.96% | -96.99% |
| Immuneering Corporation (IMRX)vs › | $146.66M | -32.73% | -84.24% | -68.85% | -57.28% |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | -7.95% | -23.12% | -29.64% | -23.50% |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $150.59M | -23.41% | -38.99% | -40.72% | -30.95% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $137.56M | -7.01% | -1.96% | -0.91% | 1.75% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $153.31M | -165.56% | -176.54% | -127.81% | -112.12% |
| Anavex Life Sciences Corp. (AVXL)vs › | $153.84M | -27.25% | -49.08% | -43.31% | -52.54% |
ROIC
-10.8%
ROE
68.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -10.85% |
| 2026-03-31 | -21.09% |
| 2025-12-31 | -51.83% |
| 2025-09-30 | -69.90% |
| 2025-06-30 | -101.98% |
| 2025-03-31 | -93.67% |
| 2024-12-31 | -154.93% |
| 2024-09-30 | -182.77% |
| 2024-06-30 | -133.61% |
| 2024-03-31 | -138.66% |
| 2023-12-31 | -166.25% |
| 2023-09-30 | -284.20% |
| 2023-06-30 | -305.19% |
| 2023-03-31 | -151.86% |
| 2022-12-31 | -115.16% |
| 2022-09-30 | -93.18% |
| 2022-06-30 | -78.84% |
| 2022-03-31 | -64.73% |
| 2021-12-31 | -61.44% |
| 2021-09-30 | -46.04% |
| 2021-06-30 | -34.21% |
| 2021-03-31 | -29.83% |
| 2020-12-31 | -32.73% |
| 2020-09-30 | -38.80% |
| 2020-06-30 | -42.77% |
| 2020-03-31 | -52.07% |
| 2019-12-31 | -58.94% |
| 2019-09-30 | -60.15% |
| 2019-06-30 | -60.00% |
| 2019-03-31 | -74.68% |
| 2018-12-31 | -117.56% |
| 2018-09-30 | -66.50% |
| 2018-06-30 | -64.77% |
| 2018-03-31 | -59.38% |
| 2017-12-31 | -52.78% |
| 2017-09-30 | -48.84% |
| 2017-06-30 | -37.64% |
| 2017-03-31 | -41.49% |
| 2016-12-31 | -56.55% |
| 2016-09-30 | -55.32% |
| 2016-06-30 | -72.77% |
| 2016-03-31 | -56.92% |
| 2015-12-31 | -46.77% |
| 2015-09-30 | -54.67% |
| 2015-06-30 | -37.02% |
| 2015-03-31 | -30.93% |
| 2014-12-31 | -24.22% |
| 2014-09-30 | -29.86% |
| 2014-06-30 | -32.45% |
| 2014-03-31 | -37.44% |
| 2013-12-31 | -37.44% |
| 2013-09-30 | -33.38% |
| 2013-06-30 | -51.03% |
| 2013-03-31 | -68.40% |
| 2012-12-31 | -75.78% |
| 2012-09-30 | -55.27% |
| 2012-06-30 | -63.09% |
| 2012-03-31 | -134.37% |
| 2011-12-31 | -176.26% |
| 2011-09-30 | -139.32% |
